Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 848 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22099021T>A |
| Variant | c.949T>A |
| Variant Start Position | 949 |
| Location | Exon 9 |
| Amino Acid Change | p.Tyr317Asn |
| ACMG Call | - |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Likely Pathogenic | Effect Type | Missense |
| Variant Type | SNV |
| PMID | 32329911, 34806794 |
| Article Count | 2 |
| Times Observed | < 3 |
| Clinical Phenotype | - |
| ACMG Categories | pm2, pm5, pp3, ppc |
| ACMG Explanations | pm2: chrX:22117139 ref:T alt:A was not found in gnomAD exomes or genomes. pm5: This is a missense variant at an amino acid residue where a different missense change has been established as pathogenic. pp3: The SIFT, MutationTaster, and PolyPhen predictions agree that this variant is possibly or probably damaging. |
| Variant in Clinvar | No |
| ClinVar Classification | - |
| Categories In Literature | ppc |
| No Contrary Evidence Found | TRUE |
| ExAC Allele Frequency | 0 |
| Thousand Genomes Allel Frequency | 0 |
| Ontology Relations | - |
| hg19 Mapping Failed | FALSE |
| Literature Alleles | - |
| GnomAD Alleles | - |
| DBNSFP Alleles | X-22117139-T-A |
| Other Alleles | X-22117139-TAC-AAT |
| Note | nan |
| Warnings | - |